An updated patent review of glutaminase inhibitors (2019–2022)-Reference-Cited by-同舟云学术

An updated patent review of glutaminase inhibitors (2019–2022)

Published:2023-01-02 Issue:1 Volume:33 Page:17-28
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Wang Danni¹,Li Xiaohong¹,Gong Guangyue¹,Lu Yulong¹,Guo Ziming¹,Chen Rui¹,Huang Huidan²,Li Zhiyu¹,Bian Jinlei¹

Affiliation:

1. State Key Laboratory of Natural Medicines and Jiang Su Key Laboratory of Drug Design and Optimization, Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, China

2. Department of Pharmaceutical Engineering, School of Pharmacy, Wannan Medical College, Wuhu, China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province of China

Natural Science Foundation of Anhui Province of China

Science Foundation of Jiangsu Province for Excellent Young Scientists

Qinglan Project of Jiangsu Province of China, and the National Innovation and Entrepreneurship Training Program for Undergraduate

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2023.2173573

Reference83 articles.

1. Fundamentals of cancer metabolism

2. Hallmarks of Cancer: The Next Generation

3. Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate

4. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

5. Otto Warburg's contributions to current concepts of cancer metabolism

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent progress in carbene-catalyzed fluoroalkylation;Science China Chemistry;2024-06-26

2. Recent Progress of Glutathione Peroxidase 4 Inhibitors in Cancer Therapy;Mini-Reviews in Medicinal Chemistry;2024-06-14

3. A glutamine tug-of-war between cancer and immune cells: recent advances in unraveling the ongoing battle;Journal of Experimental & Clinical Cancer Research;2024-03-08

4. ZSWIM4 inhibition improves chemosensitivity in epithelial ovarian cancer cells by suppressing intracellular glycine biosynthesis;Journal of Translational Medicine;2024-02-21

5. Recent advances in metal-free catalytic enantioselective higher-order cycloadditions;Organic Chemistry Frontiers;2024